These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23759508)

  • 1. In vivo cardiovascular pharmacology of 2',3'-cAMP, 2'-AMP, and 3'-AMP in the rat.
    Jackson EK; Mi Z
    J Pharmacol Exp Ther; 2013 Aug; 346(2):190-200. PubMed ID: 23759508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
    Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Jackson EK
    J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2',3'-cAMP, 3'-AMP, and 2'-AMP inhibit human aortic and coronary vascular smooth muscle cell proliferation via A2B receptors.
    Jackson EK; Ren J; Gillespie DG
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H391-401. PubMed ID: 21622827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.
    Gottlieb SS; Brater DC; Thomas I; Havranek E; Bourge R; Goldman S; Dyer F; Gomez M; Bennett D; Ticho B; Beckman E; Abraham WT
    Circulation; 2002 Mar; 105(11):1348-53. PubMed ID: 11901047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic effect of adenosine A1-receptor blockade in rats.
    Oberbauer R; Schreiner GF; Meyer TW
    Nephrol Dial Transplant; 1998 Apr; 13(4):900-3. PubMed ID: 9568847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal effects of adenosine 3',5'-cyclic monophosphate and dibutyryl adenosine 3',5'-cyclic monophosphate. Evidence for a role for adenosine 3',5'-cyclic monophosphate in the regulation of proximal tubular sodium reabsorption.
    Gill JR; Casper AG
    J Clin Invest; 1971 Jun; 50(6):1231-40. PubMed ID: 4326154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular 2',3'-cAMP-adenosine pathway in proximal tubular, thick ascending limb, and collecting duct epithelial cells.
    Jackson EK; Gillespie DG
    Am J Physiol Renal Physiol; 2013 Jan; 304(1):F49-55. PubMed ID: 23077101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine response of the rat kidney after saline loading, sodium restriction and hemorrhagia.
    Osswald H; Schmitz HJ; Heidenreich O
    Pflugers Arch; 1975 Jun; 357(3-4):323-33. PubMed ID: 1238994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extracellular cAMP-adenosine pathway significantly contributes to the in vivo production of adenosine.
    Jackson EK; Mi Z; Dubey RK
    J Pharmacol Exp Ther; 2007 Jan; 320(1):117-23. PubMed ID: 17028245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of low-dose aminophylline and enprofylline in newborn rabbits.
    Gouyon JB; Arnaud M; Guignard JP
    Life Sci; 1988; 42(13):1271-8. PubMed ID: 3352455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular 2',3'-cAMP is a source of adenosine.
    Jackson EK; Ren J; Mi Z
    J Biol Chem; 2009 Nov; 284(48):33097-106. PubMed ID: 19801686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adenosine receptor agonists on renal function in anaesthetized rats.
    Panzacchi G; Demarchi B; Busca G; Protasoni G; Golin R; Stella A
    J Hypertens; 1997 Dec; 15(12 Pt 2):1785-9. PubMed ID: 9488240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular 2,3-cyclic adenosine monophosphate is a potent inhibitor of preglomerular vascular smooth muscle cell and mesangial cell growth [corrected].
    Jackson EK; Ren J; Gillespie DG; Dubey RK
    Hypertension; 2010 Jul; 56(1):151-8. PubMed ID: 20516392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A1 receptor antagonist blunts urinary potassium excretion, but not renal hemodynamic effects, induced by carbonic anhydrase inhibitor in rats.
    Zhou X; Kost CK
    J Pharmacol Exp Ther; 2006 Feb; 316(2):530-8. PubMed ID: 16278313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of rolipram and cilostamide on renal functions and cyclic AMP release in anesthetized dogs.
    Tanahashi M; Hara S; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1533-8. PubMed ID: 10336549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors.
    Patinha D; Fasching A; Pinho D; Albino-Teixeira A; Morato M; Palm F
    Am J Physiol Renal Physiol; 2013 Mar; 304(5):F614-22. PubMed ID: 23283998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac fibroblasts express the cAMP-adenosine pathway.
    Dubey RK; Gillespie DG; Mi Z; Jackson EK
    Hypertension; 2000 Sep; 36(3):337-42. PubMed ID: 10988261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of adenosine in renal protection induced by a brief episode of ischemic preconditioning in rats.
    Sugino H; Shimada H; Tsuchimoto K
    Jpn J Pharmacol; 2001 Oct; 87(2):134-42. PubMed ID: 11700012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II: enhanced renal responsiveness in young genetically hypertensive rats.
    Vyas SJ; Jackson EK
    J Pharmacol Exp Ther; 1995 May; 273(2):768-77. PubMed ID: 7752079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adenosine A2A receptor agonist, CGS 21680, on blood pressure, cardiac index and arterial conductance in anaesthetized rats.
    Nekooeian AA; Tabrizchi R
    Eur J Pharmacol; 1996 Jun; 307(2):163-9. PubMed ID: 8832218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.